Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Uranium One upsizes private placement to $2M for exploration and development funding

Company Fundamentals
01 May 2026
TheNewswire
View Source
Bullish
pluang ai news

Uranium One Mining Corp. has increased its non-brokered private placement to raise up to CAD 2 million through the sale of flow-through and non-flow-through units priced at CAD 0.30 each. The offering includes warrants exercisable at CAD 0.50 per share, with potential accelerated expiry if the share price hits CAD 0.75. Proceeds will fund exploration, drilling, property payments, and working capital for uranium and battery metals projects in Canada, Paraguay, and Argentina. The company expects closings in mid and late May 2026, pending regulatory approvals.

More News

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom Industries reported a record first quarter with contract revenues up 56.1% to $1.965 billion and adjusted net income nearly doubling to $134.3 million. The company raised its full-year fiscal 2027 revenue outlook to $7.38-$7.65 billion, driven ...

Company Fundamentals
Bullish
20 minutes ago
BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog, part of Tilray Brands, is rolling out a major summer campaign across the UK tied to the global football tournament. The campaign features a "Win a Year of Beer" contest with special cans hidden in over 2.8 million packs at major retailers, p...

Market News
Bullish
20 minutes ago
Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics, a biopharmaceutical company specializing in next-generation T cell therapies, announced it will present at two upcoming investor conferences: William Blair’s Growth Stock Conference on June 2 and Jefferies Global Healthcare Conf...

Market News
Neutral
20 minutes ago
G-III Apparel Group declares quarterly dividend of $0.10 per share payable July 8, 2026.

G-III Apparel Group declares quarterly dividend of $0.10 per share payable July 8, 2026.

G-III Apparel Group announced a quarterly cash dividend of $0.10 per share, payable on July 8, 2026, to shareholders of record as of June 22, 2026. This dividend reflects the company's ongoing commitment to returning value to its investors. G-III is ...

Company Fundamentals
Neutral
20 minutes ago
Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharmaceuticals announced Phase 1 results indicating their Hepatitis C treatment regimen, combining bemnifosbuvir and ruzasvir, has a low risk of drug-drug interactions with common medications like omeprazole and rosuvastatin. This supports easi...

Market News
Bullish
20 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App